{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:48:57Z","timestamp":1790740137379,"version":"4.1.0"},"reference-count":81,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T00:00:00Z","timestamp":1539302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Patients with chronic kidney disease (CKD) display an elevated risk of thrombosis. Thrombosis occurs in cardiovascular events, such as venous thromboembolism, stroke, and acute coronary syndrome, and is a cause of hemodialysis vascular access dysfunction. CKD leads to the accumulation of uremic toxins, which exerts toxic effects on blood and the vessel wall. Some uremic toxins result from tryptophan metabolization in the gut through the indolic and the kynurenine pathways. An increasing number of studies are highlighting the link between such uremic toxins and thrombosis in CKD. In this review, we describe the thrombotic mechanisms induced by tryptophan-derived uremic toxins (TDUT). These mechanisms include an increase in plasma levels of procoagulant factors, induction of platelet hyperactivity, induction of endothelial dysfunction\/ impairment of endothelial healing, decrease in nitric oxide (NO) bioavailability, and production of procoagulant microparticles. We focus on one important prothrombotic mechanism: The induction of tissue factor (TF), the initiator of the extrinsic pathway of the blood coagulation. This induction occurs via a new pathway, dependent on the transcription factor Aryl hydrocarbon receptor (AhR), the receptor of TDUT in cells. A better understanding of the prothrombotic mechanisms of uremic toxins could help to find novel therapeutic targets to prevent thrombosis in CKD.<\/jats:p>","DOI":"10.3390\/toxins10100412","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T10:54:03Z","timestamp":1539341643000},"page":"412","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease"],"prefix":"10.3390","volume":"10","author":[{"given":"Tawfik","family":"Addi","sequence":"first","affiliation":[{"name":"Aix Marseille University, INSERM, INRA, C2VN, 13005 Marseille, France"},{"name":"LPNSA, D\u00e9partement de Biologie, Universit\u00e9 d\u2019Oran 1 Ahmed Benbella, 31000 Oran, Alg\u00e9rie"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Dou","sequence":"additional","affiliation":[{"name":"Aix Marseille University, INSERM, INRA, C2VN, 13005 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1813-7884","authenticated-orcid":false,"given":"St\u00e9phane","family":"Burtey","sequence":"additional","affiliation":[{"name":"Aix Marseille University, INSERM, INRA, C2VN, 13005 Marseille, France"},{"name":"Centre de N\u00e9phrologie et Transplantation R\u00e9nale, AP-HM, 13005 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,10,12]]},"reference":[{"key":"ref_1","first-page":"19","article-title":"KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Chapter 1: Definition and classification of CKD","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int. Suppl."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality","volume":"311","author":"Coresh","year":"2014","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Di Angelantonio, E., Danesh, J., Eiriksdottir, G., and Gudnason, V. (2007). Renal function and risk of coronary heart disease in general populations: New prospective study and systematic review. PLoS Med., 4.","DOI":"10.1371\/journal.pmed.0040270"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.2011.223","article-title":"Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Herzog","year":"2011","journal-title":"Kidney Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.thromres.2014.08.014","article-title":"ISTH Steering Committee for World Thrombosis Day Thrombosis: A major contributor to global disease burden","volume":"134","author":"Raskob","year":"2014","journal-title":"Thromb. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/gft209","article-title":"Haemostasis in chronic kidney disease","volume":"29","author":"Lutz","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1053\/j.ajkd.2011.06.021","article-title":"Venous thromboembolism in patients with reduced estimated GFR: A population-based perspective","volume":"58","author":"Parikh","year":"2011","journal-title":"Am. J. Kidney Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.blre.2011.07.001","article-title":"Bleeding and thrombotic complications of kidney disease","volume":"25","author":"Pavord","year":"2011","journal-title":"Blood Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1681\/ASN.2007030308","article-title":"Chronic kidney disease increases risk for venous thromboembolism","volume":"19","author":"Wattanakit","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/jth.12141","article-title":"Risk of venous thrombosis in patients with chronic kidney disease: Identification of high-risk groups","volume":"11","author":"Ocak","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.2215\/CJN.04060318","article-title":"Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease: The Stockholm CREAtinine Measurements (SCREAM) Project","volume":"13","author":"Carrero","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/sdi.12658","article-title":"The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled","volume":"31","author":"Viecelli","year":"2018","journal-title":"Semin. Dial."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Vanholder, R., Pletinck, A., Schepers, E., and Glorieux, G. (2018). Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update. Toxins, 10.","DOI":"10.3390\/toxins10010033"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3390\/toxins6030934","article-title":"The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: A new concept to understand cardiovascular complications of chronic kidney disease","volume":"6","author":"Sallee","year":"2014","journal-title":"Toxins"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ki.2011.504","article-title":"Uremic solutes from colon microbes","volume":"81","author":"Meyer","year":"2012","journal-title":"Kidney Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000346223","article-title":"Review of protein-bound toxins, possibility for blood purification therapy","volume":"35","author":"Neirynck","year":"2013","journal-title":"Blood Purif."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1681\/ASN.2015010068","article-title":"Serum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts","volume":"27","author":"Wu","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1681\/ASN.2017080929","article-title":"Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans","volume":"29","author":"Kolachalama","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijcard.2015.03.413","article-title":"Kynurenines as predictors of acute coronary events in the Hordaland Health Study","volume":"189","author":"Eussen","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ijcard.2012.12.090","article-title":"Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study","volume":"168","author":"Sulo","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3945\/jn.116.241711","article-title":"Increases in Plasma Tryptophan Are Inversely Associated with Incident Cardiovascular Disease in the Prevenci\u00f3n con Dieta Mediterr\u00e1nea (PREDIMED) Study","volume":"147","author":"Yu","year":"2017","journal-title":"J. Nutr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1681\/ASN.2013121283","article-title":"The cardiovascular effect of the uremic solute indole-3 acetic acid","volume":"26","author":"Dou","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Karbowska, M., Kaminski, T.W., Marcinczyk, N., Misztal, T., Rusak, T., Smyk, L., and Pawlak, D. (2017). The Uremic Toxin Indoxyl Sulfate Accelerates Thrombotic Response after Vascular Injury in Animal Models. Toxins, 9.","DOI":"10.3390\/toxins9070229"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCULATIONAHA.112.118174","article-title":"Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor","volume":"127","author":"Chitalia","year":"2013","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/0192623310389474","article-title":"Current Understanding of Hemostasis","volume":"39","author":"Gale","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-0030-1248722","article-title":"Disorders of hemostasis associated with chronic kidney disease","volume":"36","author":"Jalal","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ki.2013.133","article-title":"Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway","volume":"84","author":"Gondouin","year":"2013","journal-title":"Kidney Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1681\/ASN.2014121241","article-title":"The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia","volume":"27","author":"Shivanna","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kami\u0144ski, T.W., Pawlak, K., Karbowska, M., My\u015bliwiec, M., and Pawlak, D. (2017). Indoxyl sulfate-the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease. BMC Nephrol., 18.","DOI":"10.1186\/s12882-017-0457-1"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.thromres.2009.04.011","article-title":"Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease","volume":"124","author":"Pawlak","year":"2009","journal-title":"Thromb. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1160\/TH08-10-0696","article-title":"Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients","volume":"102","author":"Pawlak","year":"2009","journal-title":"Thromb. Haemost."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11255-017-1729-1","article-title":"Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease","volume":"50","author":"Kaminski","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/MBC.0b013e32832da16d","article-title":"Tissue factor\/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment","volume":"20","author":"Pawlak","year":"2009","journal-title":"Blood Coagul. Fibrin."},{"key":"ref_38","first-page":"325","article-title":"Mild-to-moderate renal impairment is associated with platelet activation: A cross-sectional study","volume":"70","author":"Thijs","year":"2008","journal-title":"Clin. Nephrol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1055\/s-2004-835678","article-title":"Platelet dysfunction in renal failure","volume":"30","author":"Boccardo","year":"2004","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2016-10-744060","article-title":"Indoxyl sulfate induces platelet hyperactivity and contributes to chronic kidney disease-associated thrombosis in mice","volume":"129","author":"Yang","year":"2017","journal-title":"Blood"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Yau, J.W., Teoh, H., and Verma, S. (2015). Endothelial cell control of thrombosis. BMC Cardiovasc. Disord., 15.","DOI":"10.1186\/s12872-015-0124-z"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2005080834","article-title":"Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: The Hoorn study","volume":"17","author":"Stam","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cca.2010.06.019","article-title":"Mechanism of endothelial dysfunction in chronic kidney disease","volume":"411","author":"Malyszko","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1538-7836.2009.03540.x","article-title":"Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients","volume":"7","author":"Dou","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1681\/ASN.2005050615","article-title":"Hemodialysis vascular access dysfunction: A cellular and molecular viewpoint","volume":"17","author":"Sukhatme","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000452428","article-title":"Circulating Progenitor Cells Affect Thrombosis of Dialysis Arteriovenous Fistulas","volume":"44","author":"Chen","year":"2016","journal-title":"Am. J. Nephrol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1172\/JCI10881","article-title":"Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation","volume":"107","author":"Fabre","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1084\/jem.20061617","article-title":"Vascular wall\u2013produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors","volume":"204","author":"Gross","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/hh0801.089861","article-title":"Nitric oxide insufficiency, platelet activation, and arterial thrombosis","volume":"88","author":"Loscalzo","year":"2001","journal-title":"Circ. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MNH.0b013e32834d54ca","article-title":"Nitric oxide synthase derangements and hypertension in kidney disease","volume":"21","author":"Baylis","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1159\/000191468","article-title":"Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells","volume":"29","author":"Tumur","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Pieniazek, A., Gwozdzinski, L., Hikisz, P., and Gwozdzinski, K. (2018). Indoxyl sulfate generates free radicals, decreases antioxidant defense and leads to damage to mononuclear blood cells. Chem. Res. Toxicol.","DOI":"10.1021\/acs.chemrestox.8b00065"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1538-7836.2007.02540.x","article-title":"The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells","volume":"5","author":"Dou","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1538-7836.2005.01780.x","article-title":"Elevation of circulating endothelial microparticles in patients with chronic renal failure","volume":"4","author":"Faure","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/ndt\/gfn029","article-title":"Circulating microparticles in renal diseases","volume":"23","author":"Daniel","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.thromres.2010.01.036","article-title":"Formation of procoagulant microparticles and properties","volume":"125","author":"Freyssinet","year":"2010","journal-title":"Thromb. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/MBC.0b013e32832ee915","article-title":"Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT","volume":"20","author":"Connor","year":"2009","journal-title":"Blood Coagul. Fibrin."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1046\/j.1538-7836.2003.00456.x","article-title":"Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner","volume":"1","author":"Vogel","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.3390\/toxins7114390","article-title":"Indolic uremic solutes enhance procoagulant activity of red blood cells through phosphatidylserine exposure and microparticle release","volume":"7","author":"Gao","year":"2015","journal-title":"Toxins"},{"key":"ref_60","first-page":"367284","article-title":"Tissue factor, blood coagulation, and beyond: An overview","volume":"2011","author":"Chu","year":"2011","journal-title":"Int. J. Inflam."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000447096","article-title":"Indoxyl Sulfate Downregulates Mas Receptor via Aryl Hydrocarbon Receptor\/Nuclear Factor-kappa B, and Induces Cell Proliferation and Tissue Factor Expression in Vascular Smooth Muscle Cells","volume":"133","author":"Ng","year":"2016","journal-title":"Nephron"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Yisireyili, M., Saito, S., Abudureyimu, S., Adelibieke, Y., Ng, H.Y., Nishijima, F., Takeshita, K., Murohara, T., and Niwa, T. (2014). Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109268"},{"key":"ref_63","unstructured":"Addi, T., Poitevin, S., McKay, N., El Mecherfi, K.E., Kheroua, O., Jourde-Chiche, N., de Macedo, A., Gondouin, B., Cerini, C., and Brunet, P. Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor\/nuclear factor-kappa B signaling pathway in human endothelial cells, Arch. Toxicol., In press."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00360-005-0483-3","article-title":"Dioxin: A review of its environmental effects and its aryl hydrocarbon receptor biology","volume":"175","author":"Mandal","year":"2005","journal-title":"J. Comp. Physiol. B"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1124\/dmd.115.064246","article-title":"Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation","volume":"43","author":"Hubbard","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.bcp.2008.10.013","article-title":"The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxin-activated Ah receptor to cause toxic effects","volume":"77","author":"Matsumura","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bcp.2008.08.031","article-title":"The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways","volume":"77","author":"Puga","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"eaam8475","DOI":"10.1126\/scitranslmed.aam8475","article-title":"Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk","volume":"9","author":"Shashar","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.kint.2017.11.010","article-title":"Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease","volume":"93","author":"Dou","year":"2018","journal-title":"Kidney Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2141.2010.08548.x","article-title":"The aryl hydrocarbon receptor (AHR) transcription factor regulates megakaryocytic polyploidization","volume":"152","author":"Lindsey","year":"2011","journal-title":"Br. J. Haematol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1182\/blood-2015-09-670208","article-title":"Aryl hydrocarbon receptor-dependent enrichment of a megakaryocytic precursor with a high potential to produce proplatelets","volume":"127","author":"Strassel","year":"2016","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/jth.12490","article-title":"Platelets from mice lacking the aryl hydrocarbon receptor exhibit defective collagen-dependent signaling","volume":"12","author":"Lindsey","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.toxlet.2015.03.005","article-title":"TCDD and omeprazole prime platelets through the aryl hydrocarbon receptor (AhR) non-genomic pathway","volume":"235","author":"Pombo","year":"2015","journal-title":"Toxicol. Lett."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Simeoni, M., Citraro, M.L., Deodato, F., Provenzano, M., Capria, M., Comi, A., Libri, E., Andreucci, M., Puja, A., Abenavoli, L., Cocchi, M., and Fuiano, G. (2018). An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD). Eur J. Nutr., 1\u201312.","DOI":"10.1007\/s00394-018-1785-z"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.jrn.2017.06.010","article-title":"Probiotic Supplementation in Chronic Kidney Disease: A Double-blind, Randomized, Placebo-controlled Trial","volume":"28","author":"Borges","year":"2018","journal-title":"J. Ren Nutr."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1053\/ajkd.2003.50104","article-title":"Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis","volume":"41","author":"Takayama","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2215\/CJN.05240515","article-title":"Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial","volume":"11","author":"Rossi","year":"2016","journal-title":"Clin J. Am. Soc. Nephrol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Poesen, R., Mutsaers, H.A., Windey, K., van den Broek, P.H., Verweij, V., Augustijns, P., Kuypers, D., Jansen, J., Evenepoel, P., and Verbeke, K. (2015). The Influence of Dietary Protein Intake on Mammalian Tryptophan and Phenolic Metabolites. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140820"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2215\/CJN.00490114","article-title":"Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients","volume":"9","author":"Sirich","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/hdi.12414","article-title":"Reduced protein bound uraemic toxins in vegetarian kidney failure patients treated by haemodiafiltration","volume":"20","author":"Kandouz","year":"2016","journal-title":"Hemodial. Int."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.ajkd.2015.10.018","article-title":"The Associations of Plant Protein Intake with All-Cause Mortality in CKD","volume":"67","author":"Chen","year":"2016","journal-title":"Am. J. Kidney Dis."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/10\/10\/412\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:44:19Z","timestamp":1775245459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/10\/10\/412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,12]]},"references-count":81,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["toxins10100412"],"URL":"https:\/\/doi.org\/10.3390\/toxins10100412","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,12]]}}}